Stephen Mitchener - Dec 2, 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
SVP, Chief Business Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Stephen Mitchener
Stock symbol
KPTI
Transactions as of
Dec 2, 2021
Transactions value $
-$3,338
Form type
4
Date filed
12/3/2021, 05:17 PM
Previous filing
Jun 3, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale -$3.34K -499 -13.15% $6.69 3.3K Dec 2, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary sale by the reporting person.
F2 Includes 1,323 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2021.